integrated generics inc said its wholly owned development corp subsidiary has signed letter intent with underwriters lafferty and inc and bayern and inc raise three mln dlrs through unit offering company said each unit would consist two common shares priced about five dlrs each and warrant buy another share dlrs integrated said would retain controlling interest integrated said proceeds would used finance development prescription drugs which patents expire reuter 